GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: G Medical Innovations Investor Presentation, page-6

  1. 65 Posts.
    Wrong choice of words, my bad. Inconsequential would probably be more appropriate. The dilution effect would not be significant. Granting of FDA triggers Winola contract and I am sure others as well that management would have secured by then. Minimum revenue from this one contract alone is 60m+ AUD. That's larger than our current market cap. The effect of a dilution wouldn't even be a blip on the re-rate.
    Last edited by nodel: 05/08/17
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.